DBS-QoLs: Validation of a Quality of Life Assessment Tool in Adult Generalized Dystonodyskinetic Syndromes Treated by Continuous Electrical Neuromodulation

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05870020
Collaborator
(none)
146
1
44.1

Study Details

Study Description

Brief Summary

In spite of a growing interest in the evaluation of health-related quality of life in movement's disorders management, there is no tool specifically dedicated to dystonia and related syndromes that measures both the objective severity of the handicap and the patient's feelings about the surgical treatment in terms of subjective improvement. We have been working for several years at the bedside of patients operated on in the " pathologies cérébrales résistantes " Unit on the development of a related questionnaire to assess both the motor severity and the patients' feelings about the evolution of their disease under Deep Brain Stimulation (DBS).

The self-questionnaire designed would allow to a certain extent to get away from the two gold standards currently used in the field, i.e. the Burke, Fahn & Marsden Dystonia Rating Scale (BFMDRS) and the SF-36, thus facilitating the evaluation and allowing a homogenization of the practices for the different implanting centers on the french territory.

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire (DBS-QoLs)
N/A

Detailed Description

The construction of the tool in its particular design, including various targeted modules, stems from an experience of more than ten years acquired with patients treated by deep brain stimulation in the unit. The self-questionnaire thus obtained will be sent to 146 patients with generalized dystonodyskinetic syndrome, operated and followed in the unit, and submitted to various statistical analyses. The scores of the identified dimensions will be compared with the etiology of the abnormal movements (primary vs. secondary) as well as with the results obtained with the two scales currently used to evaluate abnormal movements (BFMDRS) and/or quality of life (SF-36) and finally with the patients' mood during their follow-up (BDI, STAI). Tolerance to surgery will also be measured.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
146 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Validation of a Quality of Life Assessment Tool in Generalized Dystonodyskinetic Syndromes Treated With Continuous Electrical Neuromodulation (CEN): The "Dystono-dyskinetic BrethoméSanrey Quality of Life" Scale (DBS-QoLs)
Anticipated Study Start Date :
May 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2026
Anticipated Study Completion Date :
Jan 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adults with dystono-diskinetic syndrome treated by depp brain stimulation in the unit.

Other: Questionnaire (DBS-QoLs)
The DBS-QoLs questionnaire will be sent to the patients for answer: The questonnaire will be sent at : the inclusion 15 days after the inclusion 1 year after the inclusion

Outcome Measures

Primary Outcome Measures

  1. Ability to perform different activities assessed by DBS-QOLs [1 year]

    Ability to perform different activities assessed by the Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale (DBS-QOLs) with the evaluation of the ability to perform different activities (from impossible to autonomous) and then to estimate the evolution of this ability since the intervention (worsening, no change, improvement)

  2. Psycho-social assessment by DBS-QOLs [1 year]

    Psychosocial assessment by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no/partially questions related to the emotional and psychological perception of patients and then to estimate the evolution of this thought since the intervention (worsening, no change, improvement)

  3. Intervention's assessment by DBS-QOLs [1 year]

    Intervention's assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with yes/no question related to the intervention.

  4. Life's Quality assessment by DBS-QOLs [1 year]

    Life's Quality assessment by "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with squales from 0 (worst case) to 10 (best case).

Secondary Outcome Measures

  1. External validity of the DBS-QOLs compared to the BFMDRS for the functional subscale [1 year]

    Comparison between the "Functional" subscale of the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the total score obtained on the Functional dimension (Mobility + Activity of Daily Living) of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).

  2. External validity of the DBS-QOLs compared to the Beck Depression Inventory score for Thumia [1 year]

    Comparison of the Thumia score assessed by the Beck Depression Inventory score & the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the answer the the emotional and psychological perception of patients which have 12 items (Impossible, third person help, technology help, autonomous)

  3. External validity of the DBS-QOLs compared to the SF-36 for Life's quality [1 year]

    Comparison of the Life's quality assessed by the Short Form (36) Health Survey (SF-36) and by the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) with different yes/no question

  4. External validity of the reproducibility of the DBS-QOLs compared to the BFMDRS [1 year]

    Comparison of the sentivity to change between the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) through the evolution of the answer of DBS-QoLs and BFMDRS during the following of the patient.

  5. External validity according to different clinical criteria or scales : sensitivity to change [1 year]

    Sensitivity to change (assessment of changes during follow-up by the BFMDRS).

  6. Assessment of the correlation between the functional fain & the benefit felt by the patient with the DBS-QOLs [1 year]

    Assessment of the correlation between the measure of benefit in terms of functional gain and the benefit experienced by the patient with all the answer of all module in "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs).

  7. Assessment of the tolerance to surgery by the DBS-QOLs [1 year]

    Assessment of the tolerance to surgery through the "surgical" module of the "Dystono-dyskinetic Brethomé-Sanrey Quality of Life scale" (DBS-QOLs) which is composed of yes/no questions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adulte between 18 an 80 years

  • Patient with a generalized dystono-dyskinetic syndrome treated by Electrical Neuromodulation Continue and follow-up in the unit

  • Subject affiliated to the French social security system

Exclusion Criteria:
  • non-French speaker

  • patients who are physically unable to answer the questionnaire and who have no trusted person to help

  • severe cognitive impairment (MoCA <10, MDRS <123, PM-38 <70)

  • lack of informed consent

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT05870020
Other Study ID Numbers:
  • RECHMPL22_0228
First Posted:
May 23, 2023
Last Update Posted:
May 23, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 23, 2023